Search company, investor...
CureMetrix company logo

CureMetrix

curemetrix.com

Founded Year

2014

Stage

Loan | Alive

Total Raised

$250K

Last Raised

$250K | 3 yrs ago

About CureMetrix

CureMetrix is a developer of investigational physics-based artificial intelligence and deep machine learning solutions to help radiologists get more accurate readings of breast images

Headquarters Location

9404 Genesee Ave Suite 330

La Jolla, California, 92037,

United States

858-333-5830

Missing: CureMetrix's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: CureMetrix's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Expert Collections containing CureMetrix

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

CureMetrix is included in 7 Expert Collections, including Digital Health.

D

Digital Health

21,956 items

Startups recreating how healthcare is delivered

W

Women's Health & Wellness

1,482 items

Startups focused on providing products and services catering to women's health and wellbeing.

A

Artificial Intelligence

9,442 items

This collection includes startups selling AI SaaS, using AI algorithms to develop their core products, and those developing hardware to support AI workloads.

M

Medical Devices

11,846 items

Companies developing medical devices (per the IMDRF's definition of "medical device"). Includes software, lab-developed tests (LDTs), and combination products. *Columns updated as regularly as possible.

B

Biopharma Tech

5,241 items

Companies involved in the research, development, and commercialization of chemically- or biologically-derived therapeutic & theranostic drugs. Excludes vitamins/supplements, CROs/clinical trial services.

H

Health IT

10,541 items

This collection includes public and private companies, as well as startups, that market software solutions to healthcare provider organizations.

CureMetrix Patents

CureMetrix has filed 1 patent.

The 3 most popular patent topics include:

  • Medical imaging
  • Health informatics
  • Statistical classification
patents chart

Application Date

Grant Date

Title

Related Topics

Status

8/31/2020

8/30/2022

Medical imaging, Health informatics, Image processing, Statistical classification, Medical tests

Grant

Application Date

8/31/2020

Grant Date

8/30/2022

Title

Related Topics

Medical imaging, Health informatics, Image processing, Statistical classification, Medical tests

Status

Grant

Latest CureMetrix News

07:00 ET Novarad Partners with CureMetrix to Advance AI-Driven Mammography

Nov 28, 2021

Enterprise PACS and healthcare solution provider secures exclusive rights to resell advanced AI functionality to U.S.-based hospitals and imaging centers News provided by Share this article Share this article SAN DIEGO, Nov. 28, 2021 /PRNewswire/ -- Novarad, a leader in the development of medical imaging software, today announced a partnership with CureMetrix, Inc., a pioneering healthcare technology company that delivers artificial intelligence (AI)-driven solutions for radiology. Novarad's imaging tools, integrated with the CureMetrix AI-driven women's health suite of tools for mammography, will be distributed nationally in the U.S.  Novarad will be the exclusive PACS distributor of CureMetrix AI for small and midsized imaging centers and hospitals. NovaMG PRO with CureMetrix brings cutting-edge AI to mammography at an affordable price, without requiring users to switch workstations to view mammographic studies. "Our vision for transformative imaging technology aligns perfectly with the mission of CureMetrix to support and advance women's health," said David Grandpre, Senior Director of Product at Novarad. "By integrating these highly trained, proven algorithms with our existing mammography offerings, radiologists will be able to streamline their workflow, reduce false positives and enhance their ability to diagnose breast cancer earlier. That's why we are excited to bring CureMetrix AI for mammography to Novarad customers and help save more lives." The potential impact of the CureMetrix AI innovations in radiology have been featured in both the Journal of the American College of Radiology (JACR) and in the Journal of Digital Imaging (JDI). CureMetrix's FDA-cleared cmTriage® is an application that prioritizes suspicious cases directly into the radiology worklist. Mammography exams are then processed by cmAssist®, a sophisticated AI-based CAD algorithm intended to identify, mark and score suspicious lesions to support the radiologist. And then cmDensity™ automatically classifies the patient's breast density according to the standards set by the American College of Radiology (ACR), BIRADS Fifth Edition. Studies have shown some of the following benefits: Fewer unnecessary patient recalls – 69% reduction in false positives vs. traditional CAD, leaving more time for accurate diagnoses Increased consistency and report automation In addition, Novarad will be collaborating with CureMetrix on the implementation of novel cmAngio™, AI-based software intended to use a woman's mammogram to help doctors assess her risk of coronary heart disease (CHD), the number one killer of women. "By integrating our AI solutions with Novarad's we can help radiologists diagnose breast cancer earlier and more accurately, and help doctors identify women at risk for CHD," said Navid Alipour, Chief Executive Officer of CureMetrix. "CureMetrix solutions will enhance the performance of physicians using Novarad's outstanding platforms, improving both clinical and financial outcomes both now and well into the future." About Novarad Located in the heart of Utah's Silicon Slopes, medical technology firm Novarad® provides industry-leading healthcare solutions that enable hospitals, imaging centers, clinics and physicians to work both smarter and faster. The company's 30+ years of success are founded on several core principles: transformative technology, a people-centered approach, and service delivery excellence. Visit Novarad at  http://www.novarad.net  for more information. About CureMetrix CureMetrix is a global leader in Artificial Intelligence for medical imaging, committed to advancing technology that improves disease detection and cancer survival rates across the globe. Its mission is to help save lives and support improved clinical and financial outcomes, delivering technology that radiologists, healthcare systems, and patients can rely on with confidence. cmTriage® is FDA-cleared for commercial use in the U.S. cmTriage® and cmAssist® are ANVISA cleared in Brazil. cmAssist®, cmAngio™, and cmDensity™ are in development and are not yet available for commercial use in the U.S. For more information about CureMetrix AI solutions for women's health, visit www.CureMetrix.com . SOURCE Novarad Corporation

CureMetrix Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

CureMetrix Rank

CureMetrix Frequently Asked Questions (FAQ)

  • When was CureMetrix founded?

    CureMetrix was founded in 2014.

  • Where is CureMetrix's headquarters?

    CureMetrix's headquarters is located at 9404 Genesee Ave Suite 330, La Jolla.

  • What is CureMetrix's latest funding round?

    CureMetrix's latest funding round is Loan.

  • How much did CureMetrix raise?

    CureMetrix raised a total of $250K.

  • Who are the investors of CureMetrix?

    Investors of CureMetrix include Paycheck Protection Program, Bold Brain Ventures, EvoNexus, La Costa Investment Group, Keshif Ventures and 3 more.

  • Who are CureMetrix's competitors?

    Competitors of CureMetrix include Xylexa.

Compare CureMetrix to Competitors

ScreenPoint Medical Logo
ScreenPoint Medical

ScreenPoint Medical, based in Nijmegen, has developed smart software for improving results of breast cancer screening. This software reads mammograms like a human reader and supports radiologists by identifying and interpreting potential problem areas on x-ray images. This reduces the chance of missing tumors and may be used to organize screening more efficiently.

X
Xylexa

Xylexa is developing an AI-enabled Computer-aided Diagnostics (CADx) platform to assist caregivers with automated, accurate, timely and cost-effective medical image diagnosis.

Lunit Logo
Lunit

Lunit is a medical AI software company devoted to providing AI solutions for cancer diagnostics and therapeutics. With its deep learning technology, Lunit makes data-driven medicine the new standard of care. Lunit AI solutions help discover cancer and predict cancer treatment response by finding the right diagnosis at the right costs and the right treatment for the right patients. Lunit was founded in 2013 and is based in Seoul, South Korea.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.